Big Week Ahead: Apple, Amgen and Autos in Focus

Today is the Russell 2000 rank cut-off for the December review. Ninety-seven names hang in the balance, with 97 companies fighting to hold or gain index positions at the close. ORTEX Index Rebalance Radar shows Health Catalyst sitting exactly on the $135M entry line.

ERIE kicks off US earnings today. The insurer reports before the market opens.

Sunday brings AMGN and CRBG. Amgen posts its quarterly figures on Monday, November 3. Corebridge Financial calls analysts the same morning.

The biggest print of the week arrives Sunday night. AAPL releases Q4 results on November 2 after the bell. The $5 trillion company gives the clearest reading yet on consumer spending and services growth.

ALL and COR both report Tuesday, November 4. Allstate's print follows a period of elevated catastrophe claims. Cencora, the drug distributor, reports at the same time.

In Europe, SAF reports today alongside URW. Both carry over $10B in market cap.

On the auto front, ORTEX alt data shows Austrian car registration data running 9% above last year's same quarter as Kia reports today. That dataset leads Kia revenue by 45 days. RACE reports Thursday. Austrian registration data runs 75% below last year for that period, a weak leading signal for Ferrari's revenue line.

HMC reports Thursday. Japanese car registration data, which leads Honda revenue by 65 days with a strong fit, is running 10% below last year.

No IPOs are scheduled this week.